Kynurenines in neurodegenerative disorders: Therapeutic consideration

Research output: Contribution to journalArticle

24 Citations (Scopus)
Original languageEnglish
Pages (from-to)169-183
Number of pages15
JournalAdvances in Experimental Medicine and Biology
Volume541
Publication statusPublished - 2003

Fingerprint

AIDS Dementia Complex
Neurodegenerative diseases
Kynurenine
Central Nervous System Diseases
Prodrugs
Enzyme Inhibitors
Down Syndrome
Neurodegenerative Diseases
Multiple Sclerosis
Schizophrenia
Animals
Ischemia
Therapeutics

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

@article{fa7b4702af62484ca4a77cbf10715f6e,
title = "Kynurenines in neurodegenerative disorders: Therapeutic consideration",
author = "P. Kliv{\'e}nyi and J. Toldi and L. V{\'e}csei",
year = "2003",
language = "English",
volume = "541",
pages = "169--183",
journal = "Advances in Experimental Medicine and Biology",
issn = "0065-2598",
publisher = "Springer New York",

}

TY - JOUR

T1 - Kynurenines in neurodegenerative disorders

T2 - Therapeutic consideration

AU - Klivényi, P.

AU - Toldi, J.

AU - Vécsei, L.

PY - 2003

Y1 - 2003

UR - http://www.scopus.com/inward/record.url?scp=0347024127&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0347024127&partnerID=8YFLogxK

M3 - Article

C2 - 14977214

AN - SCOPUS:0347024127

VL - 541

SP - 169

EP - 183

JO - Advances in Experimental Medicine and Biology

JF - Advances in Experimental Medicine and Biology

SN - 0065-2598

ER -